Therapeutic potential of protease-activated receptor-1 antagonists

Author： Derian Claudia K   Maryanoff Bruce E   Zhang Han-Cheng   Andrade-Gordon Patricia  

Publisher： Informa Healthcare

ISSN： 1354-3784

Source： Expert Opinion on Investigational Drugs, Vol.12, Iss.2, 2003-02, pp. : 209-221

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Vorapaxar: a novel protease-activated receptor-1 inhibitor

By Gurbel Paul A   Jeong Young-Hoon   Tantry Udaya S  

Expert Opinion on Investigational Drugs, Vol. 20, Iss. 10, 2011-10 ,pp. : 1445-1453

Informa Healthcare

Access to resources Recommend Favorite

Protease-activated receptors: potential therapeutic targets in irritable bowel syndrome?

By Gloro Romain   Ducrotte Philippe   Reimund Jean-Marie  

Expert Opinion on Therapeutic Targets, Vol. 9, Iss. 5, 2005-10 ,pp. : 1079-1095

Informa Healthcare

Access to resources Recommend Favorite

Potential therapeutic targets for neurokinin-1 receptor antagonists

By Duffy Ruth A  

Expert Opinion on Emerging Drugs, Vol. 9, Iss. 1, 2004-05 ,pp. : 9-21

Informa Healthcare

Access to resources Recommend Favorite

Pharmacological characterization of protease-activated receptor (PAR-1) in rat astrocytes

By Debeir T.   Vige X.   Benavides J.  

European Journal of Pharmacology, Vol. 323, Iss. 1, 1997-03 ,pp. : 111-117

Elsevier

Access to resources Recommend Favorite

G-Protein Coupled Receptor Antagonists-1: Protease Activated Receptor-1 (PAR-1) Antagonists as Novel Cardiovascular Therapeutic Agents (Hot Topic: Structure and property Approaches in Recent Drug Discovery Guest Editor: Guo Zhu Zheng)

By  

Current Topics in Medicinal Chemistry, Vol. 3, Iss. 10, 2003-06 ,pp. : 1115-1123

Bentham Science Publishers

Access to resources Recommend Favorite